QT Prolongation Draft Guidance Urges Single Clinical Trial For Evaluation
This article was originally published in The Pink Sheet Daily
Executive Summary
The ECG trial should be early in clinical development (but not the first study) should be carried out in healthy volunteers and include a positive control group, FDA’s draft guidance says.
You may also be interested in...
FDA Will Accept QT/QTc Comments Through Mid-February
The agency is reopening the comment period for the International Conference on Harmonization QT prolongation draft guidances after a request from Wyeth. The comment period had ended in December.
FDA Will Accept QT/QTc Comments Through Mid-February
The agency is reopening the comment period for the International Conference on Harmonization QT prolongation draft guidances after a request from Wyeth. The comment period had ended in December.
FDA To Expand QT/QTc Prolongation Database
The agency is collecting pre-clinical and clinical studies pertaining to QT/QTc prolongation to support a discussion about the use of pre-clinical data. FDA hopes to present the data at the International Conference on Harmonization meeting next year.